CEACAM5 and colorectal cancer: Similarly, the observational study [18] on genetic biomarkers compared a novel 2-gene dataset (methylated BCAT1 and IKZF1) with CEA and concluded that the set of 2-gene biomarkers yielded significantly higher sensitivity for diagnosing recurrent colorectal cancer than the CEA biomarker.